MMS Group has acquired TMI-Orion and TMI-USA activities to complement and reinforce JRI and CIET Pharma existing offer with validation solutions designed for harsh environment

Event By Amine 5 minutes de lecture 20/01/26 at 9h42

Paris, January 20th, 2026 

The Metrology & Monitoring Solutions – MMS Group, a global leader in metrology and temperature monitoring for pharmaceuticalhealthcarefood and other regulated industries, announces the strategic acquisition of TMI-Orion and TMI-USA activities. The integration of TMI solutions will strengthen JRI and CIET Pharmas portfolio with TMI‘s 30+ years of expertise in reliable, user-friendly loggers and software for harsh environment validation

Pascal Vermeersch (President of MMS) is proud to onboard Alexander Kuhnel (current CEO of TMI-Orion) and  
Guillaume Favre (current CEO of TMI-USA) in MMS Group along with IK Partners. The MMS Group now employs circa 200 experts in 8 geographic areas with customers in 65 countries

Measurement, monitoring, validation in all environments: JRI, TMI and CIET Pharma cover the entire value chain for quality control management

The TMI integration creates perfect synergies across all MMS entities for product R&D and software innovation, quality procedures, metrology and validation capabilities as well as customer support worldwide. The three companies offer complementary expertise: JRI’s IoT sensors and JRI-MySirius platform track temperature, humidity, CO₂, and particles in real time, complemented by TMI’s validation and qualification solution in extreme environment and CIET Pharma’s qualification, mapping, and compliance services.


3 companies offering a complete and complementary range of services and products to meet the expectations of the most demanding customers, each with its own area of expertise

Worldwide coverage :

TMI and JRI share a common DNA when it comes to metrology, quality management and customer satisfaction.

As well as having a complementary product offering and R&D expertise to meet the needs of similar customers, the two companies also have solid expertise in metrology, data management (collection, transfer, storage and integrity) and quality and regulatory compliance (ISO 17025, GxP, FDA 21 CFR part 11, HACCP, FD X15-140, etc.). They are also aligned on the same high standards of customer support, satisfaction andsocial and environmental commitment.

TMI is an expert in validation and monitoring, offering solutions adapted to extreme environments


TMI-Orion and TMI-USA are internationally recognised by world leaders in the pharmaceutical, medical, food and ceramics industries for their high precision on-board measurement solutions compatible with use in extreme environments. Their customers include GSK, Pfizer, Novartis, 3M, L’Oréal, Nestlé, Danone, Campbell’s, Hormel Foods, Wienerberger, Imerys, Lingi, Saint-Gobain, Airbus, etc. Both companies are ISO 9001 certified. Their stand-alone data loggers excel in ultra-high temperatures(steam sterilisation, ceramics and other high-temperature industrial applications with heat shields up to 1300°C), cryogenic freeze-drying (-90°C), high-pressure and ATEX zones for over 30 years.

TMI has an operational presence in the United States with full local capabilities

TMI-USA, based in Reston, Virginia, has an experienced team that performs all of TMI’s activities locally, from production and after-sales services tocustomer support and metrology services, through its in-house metrology laboratory accredited to the internationally recognised ISO/IEC 17025 standard for temperature,humidity and pressure (with ANAB certification). TMI-USA is able to offer fast delivery, after-sales service and support to customers in North and Latin America.

TMI-Dynamics supplies robotic equipment for the seabed

Established in 2018 as the robotics division of TMI, TMI-Dynamics specialises in underwater electric linear actuator and manipulator arm solutions for ROVs (Remotely Operated Vehicles) for operations in extreme underwater environments.


Pascal Vermeersch, President of MMS-JRI-TMI-CIET Pharma :
“We are thrilled to welcome the TMI-Orion, TMI-USA, and TMI-Dynamics teams to offer our current and future customers a comprehensive range of complementary premium solutions: highly reliable, user-friendly loggers and software for validation or production processes in extreme environments. This acquisition is also a great opportunity to benefit from TMI-USA full operation in the USA including an accredited metrology lab in temperature, humidity, and pressure.

Alexander Kuhnel, CEO of TMI-Orion and TMI-Dynamics:
“We are thrilled to welcome the TMI-Orion, TMI-USA, and TMI-Dynamics teams to offer our current and future customers a comprehensive range of complementary premium solutions: highly reliable, user-friendly loggers and software for validation or production processes in extreme environments. This acquisition is also a great opportunity to benefit from TMI-USA full operation in the USA including an accredited metrology lab in temperature, humidity, and pressure.

Guillaume Favre, CEO of TMI-USA: “The TMI-USA acquisition by MMS Group will empower business development actions targeted to our domestic market as well as accelerate the improvement of the datalogger product line, development of new products and features, benefiting from JRI’s technical expertise. Customer satisfaction and customer service will remain TMI-USA’s priorities”

Pierre Gallix, of IK Partner:MMS Group’s acquisition of TMI enlarges MMS range of solutions and strengthens its US market expansion. Customer satisfaction and service excellence remain unwavering priorities for the Group. It also demonstrates MMS capacity to aggregate complementary and synergetic businesses to its platform. 


As a metrology expert, JRI provides advanced solutions for monitoring temperature, humidity and other parameters in the pharmaceutical, medical and food sectors. Its solutions comply with the main standards (ISO 17025, GMP, GLP, FDA 21 CFR Part 11, HACCP, COFRAC accreditation).

CIET Pharma specialises in qualification, characterisation, sterilisation, metrology and cryogenics for the most demanding customers in the pharmaceutical industry.

IK Partners is a European private equity firm investing in medium-sized companies in the Benelux, the DACH region, France, the Nordic countries, the UK and Spain. Since 1989, it has raised over €20 billion and made more than 200 investments. IK supports companies with strong growth potential, in partnership with their management teams.

MMS contact: Pascal Vermeersch – +33 (0)6 08 50 37 82 – pascal.vermeersch@group-mms.com

Press contact: Communications Team – +33(0)1 39 96 33 35 – info@group-mms.com